Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,890.00p on 06-11-2026 at 19:35:10
Change 0.00p 0%
Buy 1,885.00p
Sell 1,884.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 944.00 at 1,890.00p
Day's Volume: 6,698,040
Last Close: 1,890.00p
Open: 1,870.50p
ISIN: GB00BN7SWP63
Day's Range 1,828.50p - 1,890.00p
52wk Range: 1,735.50p - 2,282.00p
Market Capitalisation: £75.77b
VWAP: 1,874.80579p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 944 1,890.00p Ordinary
 16:37:10 - 06-Nov-26
Sell* 1,234 1,890.00p Ordinary
 16:37:10 - 06-Nov-26
Sell* 5,942 1,890.00p Ordinary
 16:37:10 - 06-Nov-26
Sell* 786,000 1,890.00p Negotiated Trade
 16:36:42 - 06-Nov-26
Sell* 433 1,890.00p Automatic Execution
 16:35:46 - 06-Nov-26
Sell* 4,410 1,890.00p Automatic Execution
 16:35:46 - 06-Nov-26
Sell* 3,157 1,890.00p Automatic Execution
 16:35:46 - 06-Nov-26
Buy* 4,876 1,890.00p Automatic Execution
 16:35:17 - 06-Nov-26
Sell* 3,124 1,890.00p Automatic Execution
 16:35:17 - 06-Nov-26
Buy* 263 1,890.00p Automatic Execution
 16:35:14 - 06-Nov-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Nov 2026 (Fri) 1,870.50 1,890.00 1,828.50 1,890.00 6,698,040
5th Nov 2026 (Thu) 1,905.00 1,915.00 1,876.00 1,890.00 5,324,484
4th Nov 2026 (Wed) 1,815.50 1,895.50 1,802.00 1,890.00 10,738,509
3rd Nov 2026 (Tue) 1,835.00 1,848.00 1,827.00 1,827.50 5,019,111
2nd Nov 2026 (Mon) 1,831.50 1,845.50 1,824.50 1,824.50 5,438,653
30th Oct 2026 (Fri) 1,838.00 1,877.00 1,830.50 1,855.00 13,549,796
29th Oct 2026 (Thu) 1,790.00 1,842.50 1,790.00 1,814.00 9,351,620
28th Oct 2026 (Wed) 1,879.50 1,879.50 1,783.50 1,831.50 16,829,097
27th Oct 2026 (Tue) 1,907.00 1,925.50 1,902.50 1,923.50 3,982,525
26th Oct 2026 (Mon) 1,903.00 1,921.50 1,898.00 1,915.00 3,085,590
23rd Oct 2026 (Fri) 1,911.50 1,911.50 1,881.00 1,894.00 5,516,426
22nd Oct 2026 (Thu) 1,875.00 1,917.00 1,863.00 1,914.00 4,466,031
21st Oct 2026 (Wed) 1,863.50 1,884.00 1,856.50 1,868.00 11,052,161
20th Oct 2026 (Tue) 1,870.00 1,879.50 1,855.00 1,868.50 5,286,220
19th Oct 2026 (Mon) 1,871.00 1,871.00 1,851.00 1,855.00 4,924,273
16th Oct 2026 (Fri) 1,843.00 1,870.00 1,842.50 1,862.50 12,806,361
15th Oct 2026 (Thu) 1,823.50 1,876.50 1,812.00 1,868.50 12,523,051
14th Oct 2026 (Wed) 1,740.00 1,816.00 1,740.00 1,816.00 7,626,757
13th Oct 2026 (Tue) 1,797.00 1,806.50 1,753.00 1,753.00 6,612,895
12th Oct 2026 (Mon) 1,755.00 1,771.00 1,751.00 1,771.00 3,351,693
9th Oct 2026 (Fri) 1,752.00 1,771.50 1,748.50 1,750.00 6,930,730
8th Oct 2026 (Thu) 1,773.00 1,773.00 1,735.50 1,735.50 16,330,339
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
6th Nov 2026 3:00 pm RNS GSK publishes provisional dividend dates
2nd Nov 2026 3:00 pm RNS Total Voting Rights
28th Oct 2026 7:00 am RNS 3rd Quarter Results
26th Oct 2026 3:30 pm RNS Director/PDMR Shareholding
26th Oct 2026 3:30 pm RNS Ris-Rez positive Ph 3 osteosarcoma data in China
26th Oct 2026 7:05 am RNS Jemperli data show 76% complete response rate
26th Oct 2026 7:00 am RNS Positive Mo-Rez Phase Ib data in ovarian cancer
21st Oct 2026 7:00 am RNS US FDA approves Hibsago for chronic hepatitis B
19th Oct 2026 5:21 pm RNS Jemperli approved in MSI-H/dMMR rectal cancer
19th Oct 2026 7:00 am RNS Ris-Rez positive early data in lung cancer
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

UK dividends calendar - next 7 days

5th Nov 2026 14:28

Read More

IN BRIEF: Convatec hires former Fortrea, Labcorp and GSK exec as CFO

3rd Nov 2026 09:59

Convatec Group PLC - London-based medical products, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care - Hires Jill McConnell to be chief financial officer, replacing Fiona Ryder. McConnell will join the company on January 1 and take over as CFO and board director on March 1 after the release of Convatec's 2026 results on February 23. Convatec notes that McConnell brings more than 25 years of finance experience, most recently serving as CFO of New York-listed clinical research firm Fortrea Holdings Inc, with previous senior roles at Labcorp Holdings Inc and GSK PLC. At Convatec, McConnell will lead Finance, Corporate Strategy & Development, Convatec Business Services and Investor Relations, reporting to Chief Executive Officer Jonny Mason. Back in July, Convatec had said Ryder would step down as CFO, having been in post since the start of 2022. Read More

WINNERS & LOSERS: Drax jumps on AI deal, AB Foods falls on outlook

3rd Nov 2026 09:50

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON BRIEFING: Coca-Cola Europacific sales up; Shell sells LNG stake

3rd Nov 2026 08:00

(Alliance News) - Coca-Cola Europacific Partners reports higher third-quarter revenue and reaffirms its full-year outlook on Tuesday. Shell agrees to sell its stake in an Australian liquefied natural gas project for USD1.45 billion, while Convatec announces the appointment of a new chief financial officer. Read More

CORRECT: New board chairs for Adsure, EDX, Mpac and Pulsar

2nd Nov 2026 21:54

(This version provides the correct headquarters of Mpac Group PLC. The high-speed packaging and automation solutions company is based in Coventry.) Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,673.94
Change-108.72

Login to your account

Forgot Password?

Not Registered